5th – 7th March 2025
EPO will attend the 22nd International AEK Cancer Congress in Berlin
EPO is presenting posters and talks at the 22nd International AEK Cancer Congress taking place in Berlin this year.
https://www.aek-congress.org/
Antje Siegert:
Novel patient derived xenograft models of acute leukemias
Poster
Maria Stecklum:
Humanized mouse models for the preclinical evaluation of novel immune cell therapies, check point inhibitors, and immune cell engagers
Poster
Simone Rhein:
FcResolv™ hIL-15 NOG mouse model for the assessment of therapeutic antibody efficacy without the interference of murine Fc receptors and for investigation of human antibody-dependent cellular cytotoxicity mediated by NK cells FcResolv™ hIL-15 NOG mouse model for the assessment of therapeutic antibody efficacy without the interference of murine Fc receptors and for investigation of human antibody-dependent cellular cytotoxicity mediated by NK cells
Poster
Dennis Gürgen:
The ITCC-P4 consortium: Deep molecular characterization of pediatric cancer xenograft (PDX) models enable prediction of novel personalized combination treatment options for patients with childhood cancer
Novel drug concepts
Poster
Molecular profiles and drug response of ITCC-P4 patient-derived xenograft pediatric cancer models for target identification and prediction of targeted therapies
Free topic
Poster